MC1R and cutaneous mastocytosis: If these findings are confirmed, they might help to identify individuals with high risk for CM who deserves to receive additional recommendations for CM prevention and early tumor detection and/or differentiated treatment, perhaps including the targeting lineage specific MC1R signalizing pathway agents.